Abstract
The effect of glucagon on the establishment of hepadnavirus infection was studied in vitro with the duck hepatitis B virus (DHBV) model. The presence of the peptide hormone throughout infection or starting up to 8 h after virus uptake resulted in a dose-dependent reduction in the levels of intra- and extracellular viral gene products and of secreted virions. Treatment with forskolin or dibutyryl-cyclic AMP, two drugs that also stimulate the cyclic AMP (cAMP) signal transduction pathway, resulted in comparable inhibition, suggesting that the inhibitor effect is related to changes in the activity of protein kinase A. In persistently infected hepatocytes, only a slight, but continuous, decrease in viral replication was observed upon prolonged drug treatment. Time course analysis, including detection of DHBV covalently closed circular (ccc) DNA templates, revealed that glucagon acts late during the establishment of infection, at a time when the virus is already internalized, but before detectable ccc DNA accumulation in the nucleus. These data suggest that nuclear import (and reimport) of DHBV DNA genomes from cytosolic capsids is subject to cAMP-mediated regulation by cellular factors responding to changes in the state of the host...Continue Reading
References
May 1, 1992·Journal of Virology·R J Rigg, H Schaller
Mar 1, 1990·Molecular Endocrinology·G HougeS O Døskeland
Jun 1, 1990·Journal of Virology·J SummersA L Horwich
Oct 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P R GalleH Schaller
Sep 4, 1986·Nature·M J WakelamM D Houslay
Jun 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·C G UnsonR B Merrifield
Jul 1, 1987·Journal of Virology·H J SchlichtH Schaller
Dec 1, 1987·Journal of Virology·H J SchlichtH Schaller
Nov 7, 1986·Cell·J S TuttlemanJ Summers
Jan 1, 1974·Methods in Enzymology·T Posternak, G Weimann
Apr 1, 1983·Medicinal Research Reviews·N J de SouzaJ Reden
Aug 15, 1994·Virology·G M Civitico, S A Locarnini
May 1, 1994·Journal of Virology·M Yu, J Summers
Dec 1, 1993·Journal of Virology·U Klingmüller, H Schaller
Aug 1, 1993·Journal of Virology·J Köck, H J Schlicht
Jan 1, 1996·Immunity·L G GuidottiF V Chisari
Sep 1, 1996·Journal of Virology·J KöckH J Schlicht
Aug 15, 1996·Virology·C SeegerJ Hu
Sep 1, 1996·Journal of Viral Hepatitis·M Nassal, H Schaller
Nov 1, 1996·Virology·E HildtP H Hofschneider
Feb 1, 1997·Journal of Virology·M KannW H Gerlich
Mar 20, 1997·Nature·G ZhangJ H Hurley
Citations
Jan 15, 2003·Journal of Virology·Hélène MabitHeinz Schaller
Feb 9, 2000·Journal of Virology·K M Breiner, H Schaller
May 9, 2000·Journal of Virology·E V Grgacic, H Schaller
Nov 23, 2000·Journal of Virology·H Mabit, H Schaller
Mar 21, 2001·The Journal of Experimental Medicine·A A BashirovaM Carrington
Jul 5, 2007·Journal of Virology·Haitao GuoJu-Tao Guo
Jul 11, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Bo Kyung KimYun Gyu Park
Dec 19, 2000·Journal of Virology·K M BreinerH Schaller
May 24, 2000·Journal of Virology·U KlöckerU Protzer
Feb 13, 2001·Journal of Virology·H MabitH Schaller
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Stanca M CiupeAlan S Perelson
Jan 11, 2000·Journal of Virology·J T GuoC Seeger
Mar 8, 2000·Microbiology and Molecular Biology Reviews : MMBR·C Seeger, W S Mason
Jun 28, 2003·Journal of Virology·Yanyan ZhengJing-hsiung Ou
Sep 15, 1999·Proceedings of the National Academy of Sciences of the United States of America·U ProtzerH Schaller
Nov 13, 1998·Journal of Virology·K RothmannH Schaller
Sep 12, 1998·Journal of Virology·S UrbanH Schaller
Sep 10, 2002·Journal of Hepatology·Yanhua LiPeter Bannasch